Drawing for BACK TO BIOLOGY

USPTO serial 88615756

BACK TO BIOLOGY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
OPUTA, CHIOMA N
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BACK TO BIOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori Shyavitz, Esq.

Lori Shyavitz, Esq. MCCARTER & ENGLISH, LLP265 FRANKLIN STREETBOSTON, MA 02110UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in the diagnosis, prevention, management and treatment of metabolic, viral, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, opthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related conditions, diseases and disorders; Diagnostic preparations for medical use; Pharmaceutical preparations for wounds; Clinical medical reagents; Diagnostic kits comprised of medical reagents for medical and clinical use in disease testing, cancer testing, bodily fluid testing, biometric testing, cardiovascular testing, heart rate testing, organ function testing, hydration testing, and nutrition testingACTIVE—
042Pharmaceutical, medical, scientific, biopharmaceutical and biotechnology research and development; Drug discovery services; Pharmaceutical and biopharmaceutical drug development services; Providing medical and scientific research information in the field of medicine and pharmaceuticals; Medical testing for scientific purpose in the field of metabolic condition and disease, cancer, biomarkers, endocrinology diseases, central nervous system diseases and inflammatory disorders; Medical research featuring the identification and validation of disease related biomarkers; Providing on-line, non-downloadable software applications to compile and analyze scientific and medical dataACTIVE—
044Medical services; Medical testing for diagnostic or treatment purposes; Medical prognostic and theranostic screening and testing; Medical diagnostic and theranostic monitoring and reporting services; Health care services, namely, providing a database of diseases and the collection of disease data and information all for treatment and diagnostic purposes; Health care services, namely, providing a database in the field of patient diagnostic, admissions, discharge, transfer (ADT), electronic health records (EHR), molecular, biomarker, genomic medicine, and clinical data including medication and laboratory values with systems for output of customized knowledge and information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Patient outcome analysis services, namely, providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses, treatments and therapies associated with a defined set of symptoms and evaluating patient records, disease markers and environmental factors to provide patients with information about possible diagnoses, treatments and therapies; Predictive modeling of data in the fields of medicine and healthcare; Providing health information; Medical informationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 24, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 24, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 4, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 3, 2022EX5GSOU EXTENSION 5 GRANTED—
Oct 3, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 23, 2022EXT5SOU EXTENSION 5 FILED—
Sep 23, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 23, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 21, 2022EX4GSOU EXTENSION 4 GRANTED—
Mar 21, 2022EXT4SOU EXTENSION 4 FILED—
Mar 21, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 22, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 20, 2021EX3GSOU EXTENSION 3 GRANTED—
Sep 20, 2021EXT3SOU EXTENSION 3 FILED—
Sep 20, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 21, 2021DOCKASSIGNED TO EXAMINER—
Mar 11, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 9, 2021EX2GSOU EXTENSION 2 GRANTED—
Mar 9, 2021EXT2SOU EXTENSION 2 FILED—
Mar 9, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 22, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 18, 2020EX1GSOU EXTENSION 1 GRANTED—
Sep 18, 2020EXT1SOU EXTENSION 1 FILED—
Sep 18, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 24, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 28, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 28, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 8, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 19, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 14, 2019DOCKASSIGNED TO EXAMINER—
Sep 22, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 17, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance